Home

Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel

The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials, today announced the appointment of Michael Foley as President of Chemours Titanium Technologies (TT), effective February 2026. Foley succeeds Damián Gumpel, who is departing the company.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204540269/en/

Chemours appoints Michael Foley as President of Titanium Technologies

Chemours appoints Michael Foley as President of Titanium Technologies

Chemours thanks Mr. Gumpel for his contributions and wishes him well in his future endeavors. This transition reflects Chemours’ ongoing commitment to advancing its TT value-based business strategy. During this period, Chemours President and CEO Denise Dignam will provide leadership support to ensure continuity and continued progress on TT’s transformation journey.

Michael Foley joins Chemours with extensive leadership experience in the chemical industry. Most recently, he served as President & General Manager of the Formulated Specialties Business at Momentive Performance Materials, overseeing a $1 billion portfolio across five business units, eight manufacturing sites, and 2,000 employees worldwide. His career includes transformative roles in portfolio optimization, organizational restructuring, and operational excellence at Momentive, as well as leadership positions at General Electric, where he was recognized for expertise in Lean and Six Sigma methodologies. Mr. Foley holds a Bachelor of Science in Environmental Engineering and an MBA from Rensselaer Polytechnic Institute.

“We are excited to welcome Michael Foley to Chemours as President of Titanium Technologies,” said Denise Dignam, President and CEO of Chemours. “Michael’s proven track record of strategic transformation and operational leadership will be instrumental as we continue to advance our TT business and deliver value for our customers, partners, and shareholders.”

“I look forward to joining Chemours and leading the Titanium Technologies team. TT has a strong foundation and clear strategy to deliver value, and I’m eager to work with this talented team to drive innovation, strengthen partnerships, and create sustainable value for our stakeholders,” added Foley.

Chemours Titanium Technologies is one of the world’s largest manufacturers of titanium dioxide (TiO₂), serving the global coatings, laminates, and plastics markets. The company remains focused on delivering strong business results and executing its Pathway to Thrive strategy.

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers’ biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,000 employees and 28 manufacturing sites and serves approximately 2,500 customers in approximately 110 countries. For more information, visit chemours.com or follow us on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the advancement of our growth strategy and the impact of individual expertise on the company’s strategy and performance, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, have affected or may affect our business and operations and may or may not continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including in our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended September 30, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

Michael’s proven track record of strategic transformation and operational leadership will be instrumental as we continue to advance our TT business and deliver value for our customers, partners, and shareholders.

Contacts

INVESTORS

Brandon Ontjes

VP, Head of Strategy & Investor Relations

+1.302.773.3300

investor@chemours.com



NEWS MEDIA

Cassie Olszewski

Media Relations & Reputation Leader

+1.302.219.7140

media@chemours.com